
Top Healthcare Dividend Stocks: Our 5 Picks for November 2026
Healthcare dividend stocks span insurers, distributors, diagnostics, medical devices, and branded medicines in this five-stock November 2026 countdown.
Every article, report, and earnings note where BDX appears.

Healthcare dividend stocks span insurers, distributors, diagnostics, medical devices, and branded medicines in this five-stock November 2026 countdown.

Davion Healthcare Plc is set to list on Nasdaq on 2026-10-22, with a price range not disclosed and a market cap of $252,750,000. The company is coming public as a direct listing, so there is no traditional underwritten IPO bookbuild or IPO proceeds. The bull case is a pre-revenue medtech story with multiple registered products and a consumer OTC model. The bear case is that the stock starts trading without the cushion of an IPO raise, while cash remains extremely thin and execution risk is high.

DRC Medicine is a Tokyo-based healthcare and biotech company going public via a merger with Ribbon Acquisition Corp. (NASDAQ: RIBB). The setup offers a development-stage story with real upside if its mask, diagnostics, and certification pipeline advances, but shareholders should watch redemption risk and dilution closely.

A seven-stock healthcare countdown spans telehealth, devices, life-science tools, diagnostics, distribution, and managed care, with HIMS, BDX, TMO, DHR, and ABT in focus.
Generate an AI-powered research report — grades, price targets, financials, and chart analysis on demand.
Generate BDX ReportCancel anytime